Sentence examples for benefit from early invasive from inspiring English sources

Patients with normal levels of cardiac troponin measured with a high-sensitivity method (cTnT-hs) might not benefit from early invasive procedures.In this Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) blood-core substudy, 1232 patients presented with NSTE-ACS had a high sensitivity cardiac troponin T (cTnT-hs) level <99th percentile (<14 ng/l) at randomisation.

With regard to patients with NSTACS, a TACTICS-TIMI 18 TACTICS-TIMI 18analysis demonstriald that postents withocanalysisroponin I levels of less than 0.1 ng/ml hademonstratedble benefithatom early invasive management.

17 This implies that most people would be unlikely to benefit from early invasive intervention, and it would need to be postulated that a subgroup with more persistent symptoms would derive benefit.

However, according to the European guidelines, these high-risk subgroups of patients benefit most from early invasive treatments.

Unlike men, women presenting with low-risk NSTE-ACS do not seem to benefit from an early invasive approach.

Gender differences in benefit from an early invasive strategy have been debated and data are conflicting for preforming PCI in ACS patients.

In UA/NSTEMI patients >75 years of age, the benefit from an early invasive strategy was even greater in reducing the incidence of death or MI at 6 months (10.8% vs 21.6%).

Owing to their higher risk, elderly ACS patients derive greater benefit from an early invasive strategy than their younger counterparts; in UA/NSTEMI patients aged more than 65 years, an early invasive strategy compared to a conservative strategy significantly reduced the incidence of death or MI at 30 days (5.7% vs 9.8%) and six months (8.8% vs 13.6%).

Major interest was generated by studies indicating that cardiac troponins were useful for risk stratification and in identifying individuals most apt to benefit from an early invasive strategy in patients with acute coronary syndromes (ACS) [ 11– 14], and a new key role for cardiac biomarkers was added to the traditional diagnostic role.

This well-defined patient subgroup represents a substantial proportion of cases of invasive candidiasis in the ICU and might significantly benefit from early non-invasive diagnosis.

This score can differentiate patients who would benefit from early antifungal treatment from those for whom invasive candidiasis is highly improbable.